Antiallergic Effects of Technologically Processed Antibodies to MHC II

Article Properties
Cite
Petrova, N. V., et al. “Antiallergic Effects of Technologically Processed Antibodies to MHC II”. Bulletin of Experimental Biology and Medicine, vol. 175, no. 6, 2023, pp. 801-3, https://doi.org/10.1007/s10517-023-05950-8.
Petrova, N. V., Tarasov, S. A., Galkina, A. A., Poroshina, A. S., Sundukova, M. S., & Smirnov, V. V. (2023). Antiallergic Effects of Technologically Processed Antibodies to MHC II. Bulletin of Experimental Biology and Medicine, 175(6), 801-803. https://doi.org/10.1007/s10517-023-05950-8
Petrova, N. V., S. A. Tarasov, A. A. Galkina, A. S. Poroshina, M. S. Sundukova, and V. V. Smirnov. “Antiallergic Effects of Technologically Processed Antibodies to MHC II”. Bulletin of Experimental Biology and Medicine 175, no. 6 (2023): 801-3. https://doi.org/10.1007/s10517-023-05950-8.
1.
Petrova NV, Tarasov SA, Galkina AA, Poroshina AS, Sundukova MS, Smirnov VV. Antiallergic Effects of Technologically Processed Antibodies to MHC II. Bulletin of Experimental Biology and Medicine. 2023;175(6):801-3.
Refrences
Title Journal Journal Categories Citations Publication Date
Antibodies Processed Using High Dilution Technology Distantly Change Structural Properties of IFNγ Aqueous Solution

Pharmaceutics
  • Medicine: Pharmacy and materia medica
  • Medicine: Public aspects of medicine: Toxicology. Poisons
  • Medicine: Therapeutics. Pharmacology
16 2021
Insights into the Mechanism of Action of Highly Diluted Biologics

The Journal of Immunology
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
50 2020
Antibiotic Hypersensitivity Mechanisms

Pharmacy
  • Medicine: Pharmacy and materia medica
  • Medicine: Therapeutics. Pharmacology
20 2019
Fatal Anaphylaxis: Mortality Rate and Risk Factors The Journal of Allergy and Clinical Immunology: In Practice
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Medicine (General)
309 2017
Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy

Allergy
  • Medicine: Internal medicine: Infectious and parasitic diseases
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
41 2009
Refrences Analysis
The category Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy 6 is the most frequently represented among the references in this article. It primarily includes studies from Allergy and European Journal of Pharmaceutical Sciences. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year